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Neurobiology of Disease
Epilepsy-Associated KCNQ2 Channels Regulate Multiple
Intrinsic Properties of Layer 2/3 Pyramidal Neurons
Zachary Niday, XVirginia E. Hawkins, Heun Soh, XDaniel K. Mulkey, and XAnastasios V. Tzingounis
Department of Physiology and Neurobiology, University of Connecticut, Storrs, Connecticut 06269
KCNQ2potassiumchannels are critical for normal brain function, as both loss-of-function andgain-of-functionKCNQ2variants can lead
to various forms of neonatal epilepsy. Despite recent progress, the full spectrum of consequences as a result of KCNQ2 dysfunction in
neocortical pyramidal neurons is still unknown. Here, we report that conditional ablation of Kcnq2 from mouse neocortex leads to
hyperexcitability of layer 2/3 (L2/3) pyramidal neurons, exhibiting an increased input resistance and action potential frequency, as well
as a reduced medium afterhyperpolarization (mAHP), a conductance partly mediated by KCNQ2 channels. Importantly, we show that
introducing the KCNQ2 loss-of-function variant KCNQ2I205V into L2/3 pyramidal neurons using in utero electroporation also results in a
hyperexcitable phenotype similar to the conditional knock-out. KCNQ2I205V has a right-shifted conductance-to-voltage relationship,
suggesting loss of KCNQ2 channel activity at subthreshold membrane potentials is sufficient to drive large changes in L2/3 pyramidal
neuronal excitability even in the presence of an intactmAHP.We also found that the changes in excitability followingKcnq2 ablation are
accompanied by alterations at action potential properties, including action potential amplitude in Kcnq2-null neurons. Importantly,
partial inhibition of Nav1.6 channels was sufficient to counteract the hyperexcitability ofKcnq2-null neurons. Therefore, ourwork shows
that loss of KCNQ2 channels alters the intrinsic neuronal excitability and action potential properties of L2/3 pyramidal neurons, and
identifies Nav1.6 as a new potential molecular target to reduce excitability in patients with KCNQ2 encephalopathy.
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Introduction
Two decades ago, genetic studies implicated KCNQ2 and
KCNQ3 potassium channel dysfunction as a likely cause for be-
nign familial neonatal seizures (BFNSs), an epileptic neonatal
disorder characterized by seizures that spontaneously remit
within the first year of life (Charlier et al., 1998; Singh et al., 1998).
More recently, targeted and whole exome sequencing revealed
that KCNQ2 and KCNQ3 variants are also linked to severe forms
of neonatal epileptic encephalopathy, including Ohtahara syn-
drome and, potentially, infantile spasms (Saitsu et al., 2012;
Weckhuysen et al., 2012; Allen and Monyer, 2013; Kato et al.,
2013). The main features of these forms of encephalopathy are
progressive cognitive deterioration and an early onset of severe
seizures that do not respond to most antiepileptic drugs (Auvin
et al., 2016). Thus, there is a pressing need for new therapeutic
agents.
Currently, the majority of KCNQ2 encephalopathy variants
are loss-of-function and dominant negative (Orhan et al., 2014);
that is, the presence of only one copy of the variant is sufficient to
alter the properties of the tetrameric potassium channel complex.
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Significance Statement
KCNQ2 channels are critical for the development of normal brain function, as KCNQ2 variants could lead to epileptic encepha-
lopathy. However, the role of KCNQ2 channels in regulating the properties of neocortical neurons is largely unexplored. Here, we
find that Kcnq2 ablation or loss-of-function at subthreshold membrane potentials leads to increased neuronal excitability of
neocortical layer 2/3 (L2/3) pyramidal neurons. We also demonstrate that Kcnq2 ablation unexpectedly leads to a larger action
potential amplitude. Importantly, we propose the Nav1.6 channel as a newmolecular target for patients with KCNQ2 encephalop-
athy, as partial inhibition of these channels counteracts the increased L2/3 pyramidal neuron hyperexcitability of Kcnq2-null
neurons.
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These pathogenic variants most commonly result in reduced
voltage sensitivity or current density due to changes in surface
expression or themaximumprobability of opening (Orhan et al.,
2014). Despite this knowledge, it is still unclear how the loss of
KCNQ2 leads to hyperexcitability in neocortical neurons, thus
causing epileptogenesis. Furthermore, most studies using Kcnq2
transgenic mice have focused on CA1 pyramidal neurons (Peters
et al., 2005; Otto et al., 2006; Singh et al., 2008; Soh et al., 2014),
and there are no validated KCNQ2-specific inhibitors available.
Understanding the full spectrum of KCNQ2 channel function in
the neocortex is critical to uncovering how these channels con-
tribute to disease etiology and to the development of improved
therapeutic approaches.
KCNQ2 channels are enriched in the axon initial segment
(AIS)—the site of spike initiation (Pan et al., 2006; Battefeld et al.,
2014). Importantly, recent work has shown that the AIS is plastic,
such that neuronal activity typically leads to changes in its length
or localization with respect to the soma (Grubb and Burrone,
2010). In particular, chronic elevated neuronal activity could lead
the AIS to move closer to the soma or shorten its length, whereas
decreased activity may lead to the opposite effect (Kole and
Stuart, 2012). These changes can subsequently tune neuronal
excitability, and have been implicated in demyelination and An-
gelman syndrome (Kaphzan et al., 2011; Hamada and Kole,
2015). Therefore, the electrophysiological effects of disrupting
KCNQ2 in neurons might also result from alterations in the AIS.
In this study, we show that KCNQ2 ablation from neocortical
neurons leads to increased neuronal activity of layer 2/3 (L2/3)
somatosensory pyramidal neurons. Furthermore, the introduc-
tion of a KCNQ2 pathogenic variant (KCNQ2I205V) with a right-
shifted conductance-to-voltage relationship in L2/3 pyramidal
neurons using in utero electroporation (IUE) resulted in a hyper-
excitable phenotype similar toKcnq2 ablation, despite the normal
expression of a medium afterhyperpolarization (mAHP). Addi-
tionally, our results also show that L2/3 pyramidal neurons from
Kcnq2 knock-out (KO) mice have increased action potential
(AP) amplitude without observing any corresponding changes
to the AIS length measured either through Ank-G or Pan-Nav
staining. Importantly, selective pharmacological blockade of
Nav1.6 in Kcnq2-null neurons successfully counteracted the
elevated KCNQ2-induced hyperexcitability. Therefore, we
propose Nav1.6 channels as a newmolecular target for patients
with KCNQ2 encephalopathy.
Materials andMethods
All experiments were performed according to the guidelines of the Uni-
versity of Connecticut (Storrs, CT) Institutional Animal Care and Use
Committee.
Animals and genotyping.Kcnq2 conditional KO (cKO)mice have been
described before. See Soh et al., 2014 for details on the Kcnq2 transgenic
mouse line and genotyping protocols. For Nav1.6 genetic ablation, we
obtained and used the C3Fe.Cg-Scn8amed/J mouse line fromThe Jackson
Laboratory. Mice were genotyped by PCR as described on the Jax.org
website. In brief, the following three primers were included in the PCR: a
wild-type forward primer (5-TCAGGAGCAAGGTTCTAGGC-3), a
mutant forward primer (5-TACCAAAAGTCCCCATACCC-3), and
a common reverse primer (5-AGG AGT GGC GCT AAA TCT GA-3).
The primers amplified a 164 bp wild-type fragment and/or an 82 bp
mutant fragment.
Slice preparation and electrophysiology. Postnatal day 15 (P15) to P20
mice were anesthetized using isoflurane (Baxter Healthcare) and killed
by decapitation. Brains were quickly removed and placed in ice-cold
cutting solution consisting of the following: 26 mM NaHCO3, 210 mM
sucrose, 10 mM glucose, 2.5 mM KCl, 1.25 mM NaH2PO4, 0.5 mM CaCl2,
and 7 mM MgCl2. Cerebella were removed, and 300 m coronal slices
were cut using a vibratome (Microm HM 650 V, ThermoFisher Scien-
tific). Slices were then transferred to a holding chamber containing arti-
ficial CSF (aCSF) consisting of the following: 125 mM NaCl, 26 mM
NaHCO3, 2.5 mM KCl, 1 mM NaH2PO4, 1.3 mM MgCl2, 2.5 mM CaCl2,
and 12mM D-glucose. Slices were recovered at 35°C for 30min then were
left at room temperature (RT;22°C) for1 h before electrophysiolog-
ical recording. Both cutting and aCSF solutions were saturated with 95%
O2/5% CO2.
Whole-cell recordings were obtained using electrodes pulled from
thin-walled borosilicate glass capillaries (World Precision Instruments,
Sarasota, FL) that had resistances of 2–4 M when filled with recording
solution, as described below. Pyramidal neurons from L2/3 somatosen-
sory cortex were visually identified using infrared differential interfer-
ence contrast optics (Olympus BX51WI, Olympus). The internal
recording solution for whole-cell recording consisted of the following:
125 mM potassium gluconate, 20 mM KCl, 4 mM MgATP, 0.3 mM
NaGTP, 10 mM HEPES, 0.1 mM EGTA, and 10 mM phosphocreatine
(osmolarity, 278 mOsm). The pH was adjusted to 7.2–7.3 with
KOH. The previously described aCSF was used as the external bathing
solution, and contained 100 M picrotoxin, 4 M 6-cyano-7-nitroqui-
noxaline-2,3-dione (CNQX), and 25 M D-2-amino-5-phosph-
onovaleric acid (D-APV) to block GABA-mediated, AMPA-mediated,
and NMDA-mediated synaptic transmission, respectively. All reported
potential values were corrected for the liquid junction potential, calcu-
lated to be 14.4 mV. Resting membrane potential was determined in
current clamp as the potential upon break-in, before any current injec-
tion. AP threshold was defined as the membrane potential at which the
rate of depolarization reached 100 mV/ms. All recordings were per-
formed at RT using a Multiclamp 700B Amplifier (Molecular Devices),
low-pass-filtered at 2 kHz, and sampled at 10 kHz. Data were analyzed
off-line using Axograph X (Axograph), Clampfit (Molecular Devices),
Prism 7 software (GraphPad), or MATLAB (MathWorks).
In utero electroporation. Surgery was performed on pregnant female
mice of age approximately embryonic day 15 (E15; CD-1 background
from Charles River Laboratories). Mice were anesthetized first with iso-
flurane, then with a mixture of ketamine/xylazine (100/10 mg/kg, i.p.).
Full anesthetization was confirmed by the lack of response to a toe pinch.
Metacam analgesic (2 mg/kg, s.c.) was administered for 2 d following
surgery. Surgery comprised a vertical incision along the abdominal mid-
line and removal of the uterine horns. Embryos were kept moist with a
0.9% saline solution containing 1% penicillin/streptomycin. One lateral
ventricle of each embryo was pressure injected with the DNAmixture via
a pulled glass pipette (Drummond Scientific). Pressure was supplied by
pulses delivered from a Picospritzer III (Parker). The 15 l DNA mix-
tures contained the following: 1.5 g/l pCMV-hKCNQ2 WT or
pCMV-hKCNQ2I205V, 1.0 g/l pCAG-mRFP, and 1 l of 5% Fast
Green in sterile PBS, to visualize the mixture entering the embryonic
ventricle. Following mixture injection, each embryo was electroporated
by delivering four 40 V2 pulses of 50 ms duration using a BTX 830 Pulse
Generator (BTX Harvard Apparatus) coupled with BTX Tweezertrode
Electrodes.
HEK293T cell preparation and electrophysiology. Recombinant DNA
was expressed in HEK293T cells using Lipofectamine 2000 (Invitrogen)
transfection. Cells were transfected with either wild-type hKCNQ2 or
hKCNQ2I205V subcloned into a pIRES2-DsRed-Express vector (Clon-
tech), and recordings were obtained 48 h later to allow for sufficient
plasmid expression. Experiments were performed using conventional
whole-cell patch-clamp electrophysiology in voltage-clamp configura-
tion, and recordings took place at room temperature. Pipette electrodes
were pulled to have resistances of 2–4 M and were filled with an intra-
cellular solution containing the following: 132 mM potassium gluconate,
10 mM KCl, 4 mMMgATP, 20 mMHEPES, and 1 mM EGTA (osmolarity
290 mOsm). The pH was adjusted to 7.2–7.3 with KOH. Cells were
superfused in an extracellular solution containing the following: 144mM
NaCl, 2.5mMKCl, 2.25mMCaCl2, 1.2mMMgCl2, 10mMHEPES, and 22
mM D-glucose (osmolarity, 300 mOsm). The pH was adjusted to 7.2–
7.3 with NaOH. The voltage-clamp holding potential and steps were
corrected to account for a14.4 mV liquid junction potential, resulting
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in a holding potential of 70 mV with 1.5 s steps ranging from 80 to
40mV, changing in increments of 10mV. Tail currents weremeasured
at 55 mV following the step depolarization to determine the
conductance-to-voltage relationships ofKCNQ2 andKCNQ2I205V.Data
were acquired through a MultiClamp 700B Amplifier (Molecular De-
vices), low-pass Bessel filtered at 2 kHz, and sampled at 10 kHz.
Whole-cell capacitance was compensated for during each recording.
Data were analyzed using both Clampfit (Molecular Devices) and Igor-
Pro (WaveMetrics), and statistical analyses were performed with Prism 7
software (GraphPad).
Immunohistochemistry. Mice (P15) were anesthetized and perfused
with ice-cold saline followed by 1% paraformaldehyde in pH 7.4 PBS.
Brains were removed, and tissue was postfixed overnight at 4°C. Excess
fixative was removed by three washes in PBS, and 60 m tissue sections
were prepared using a vibrating blademicrotome (VT1000 S Vibratome,
Leica Biosystems). Before antibody incubations, tissue sections were
treated to unmask epitopes with 0.2 mg/ml pepsin (Sigma-Aldrich) in
0.2 MHCl at 37°C (Corteen et al., 2011) followed by three washes in PBS.
A blocking stage was then performed by incubating tissue in 10%normal
horse serum in PBS with 10% Triton X-100 (Sigma-Aldrich) for 1 h at
RT. Sections were then incubated overnight at RTwith primary antibod-
ies diluted in blocking solution as follows: 1:50 rabbit anti-ankyrin G
(AnkG; Santa Cruz Biotechnology; RRID: AB_633909), and 1:800mouse
anti-PanNaV (Sigma-Aldrich; RRID: AB_477552). After washes in
PBS, tissues were incubated for 1 h at RT with the appropriate secondary
antibodies raised in donkey, conjugated with 1:800 488DyLight or 1:500
Cy3 (both from Jackson ImmunoResearch Laboratories; RRID:
AB_2492289 and AB_2315777, respectively). Sections were washed in
PBS again before being mounted with Vectashield containing DAPI
(Vector Laboratories). Imageswere acquired using aNikonA1R confocal
microscope (Nikon Instruments), maintaining identical settings be-
tween each series of experiments and with minimal background staining
observed in the control reactions where primary antibodies were omit-
ted. For confocal photomicrographs, two-dimensional flattened images
of the projected z-stacks are presented. Image analysis was performed
using ImageJ measurement options. Briefly, freehand linear regions of
interest (ROIs) were selected for six to eight AISs per image on a single
z-plane, and mean intensity values for each channel were calculated.
Similarly, AIS ROIs were selected, and length was measured in projected
stacks (each with identical intervals and number of z-sections) in pixels
and subsequently converted to micrometers. All analyses were per-
formed in a blinded manner.
Drugs. Recordings frommouse brain slices included the following synap-
tic blockers in the extracellular solution: picrotoxin (100 M; Abcam),
CNQX (4M; Abcam), and D-APV (Abcam). Selective block of Nav1.6 was
achievedwith the tetrodotoxin (TTX) analog 4,9-anhydroTTX(ahTTX; 100
nM; Focus Biomolecules).
Statistical analysis.Data are displayed as the mean SEM, and signif-
icance was determined with a Student’s t test, a Mann–Whitney t test, or
a two-factor mixed-design ANOVA using Prism software (GraphPad).
The n values indicate the number of cells.
Results
KCNQ2 channels regulate L2/3 pyramidal neuron excitability
Although KCNQ2 channels are expressed in pyramidal neurons
of upper cortical layers, their contribution in setting neuronal
excitability is not yet clear. To examine this directly, we used
Kcnq2-cKO mice, as specific KCNQ2 pharmacological blockers
are not available. To ablate KCNQ2 channels from pyramidal
neurons, we crossed Kcnq2f/f mice to the Emx1Cre line; Emx1Cre
mice express Cre recombinase in neocortical pyramidal cells at an
early developmental stage (E10.5; Gorski et al., 2002). Previously,
we found that the majority of Emx1Cre:Kcnq2f/f mice die by the
third week of life (Soh et al., 2014). Thus, we tested the effects of
ablating KCNQ2 channels in P15–P20 pyramidal neurons. Con-
sistent with previous studies in CA1 pyramidal neurons (Soh et
al., 2014), ablation of KCNQ2 channels reduced the mAHP of
somatosensory L2/3 pyramidal neurons (control, 4.64  0.35
mV, n  15; Kcnq2 cKO, 2.94  0.44 mV, n  6; p 	 0.05,
Mann–Whitney test; Fig. 1). The mAHP is a conductance that
limits repetitive firing (Bean, 2007).
We next examined whether Kcnq2 ablation altered the intrin-
sic membrane properties of L2/3 pyramidal neurons. To induce
firing, we depolarized pyramidal neurons by injecting currents of
variable amplitude for 1 s. As shown in Figure 2, increasing the
magnitude of the injected current from 25 to 250 pA in in-
crements of 25 pA led L2/3 pyramidal neurons to fire APs in
greater number and frequency (Fig. 2A). We found that Kcnq2-
null neurons were hyperexcitable (150 pA step; control, 8.1
0.6 APs, n 21; Kcnq2 cKO, 11.3 0.5 APs, n 18; p	 0.001,
Student’s t test; Fig. 2A) and fired APs with greater initial firing
frequency—the frequencymeasured between the first two APs—
than control neurons (150 pA step; control, 13.8 1.6 Hz, n
21; Kcnq2 cKO, 21.3 2.0 Hz, n 18; p	 0.01, Student’s t test;
Fig. 2A). Similarly, the final firing frequency, measured as the
frequency of the last two APs during the depolarizing steps, in-
creased across a range of depolarizing stimuli in Kcnq2-null neu-
rons (150 pA step; control, 6.7 0.5 Hz, n 21; Kcnq2 cKO,
9.6  0.6 Hz, n  18; p 	 0.001, Student’s t test; Fig. 2A). The
input resistance, measured at resting membrane potential fol-
lowed by a small hyperpolarizing step (25 pA), of Kcnq2-null
neurons was also larger than in control pyramidal neurons (con-
trol, 239 17 M, n 21; Kcnq2 cKO, 299 18 M, n 18;
p	 0.05, Student’s t test), which is consistent with earlier studies
that used pharmacological approaches to block all KCNQ chan-
nels in pyramidal neurons (Guan et al., 2011).
The activation and deactivation kinetics of KCNQ2 channels
are slow, leading them to limit action potential firing in res-
ponse to slow depolarizing stimuli. To examine the influence of
KCNQ2 channels on the activity of gradually induced L2/3 pyra-
midal neurons, we measured excitability by using a slow ramp
protocol (100 pA/s; Fig. 2B). Similar to the step protocol, the
ramp protocol induced a greater number of APs in Kcnq2-null
neurons (control, 9.2  1.3 APs, n  10; Kcnq2 cKO, 13.8  1
APs, n  12; p 	 0.05, Student’s t test; Fig. 2B). Together, these
findings further confirm that KCNQ2 activity is critical in regu-
lating repetitive neuronal activity in L2/3 pyramidal neurons.
Figure 1. Kcnq2 ablation reduces the L2/3 pyramidal neuron medium afterhyperpolariza-
tion. Top, Representative examples of the mAHP following a brief suprathreshold stimulus (50
ms, 2 nA) in L2/3 pyramidal neurons from either control or Kcnq2-null neurons. Bottom, Sum-
mary graph showing that the peak mAHP amplitude in Kcnq2-null L2/3 pyramidal neurons is
reduced compared with control cells (control: 4.64  0.35 mV, n  15; Kcnq2 cKO:
2.94 0.44 mV, n 6; p	 0.05, Mann–Whitney test). Bar graphs plot the mean SEM
values. Asterisks indicate statistically significant differences (*p	 0.05).
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The KCNQ2 pathogenic variant KCNQ2I205V leads to
increased L2/3 pyramidal neuron excitability
KCNQ2/3 channels control neuronal excitability by the following
two interrelated mechanisms: (1) regulating input resistance and
axonal membrane potential by mediating theM-current; and (2)
mediating an mAHP following a burst of activity. However, it is
unknown whether the loss of KCNQ2-mediated mAHP,
M-current, or both is required to induce large changes in L2/3
pyramidal neuron excitability. This is particularly important as
an increased number of KCNQ2 pathogenic variants shift the
KCNQ2 voltage dependence towardmore depolarized potentials
(Millichap et al., 2016). Such shifts are expected to prevent the
opening of KCNQ2 channels at subthreshold membrane poten-
tials without necessarily altering their ability to gate the mAHP.
To address this, we expressed the KCNQ2I205V pathogenic vari-
ant, first identified in a patient with epileptic encephalopathy
(Weckhuysen et al., 2012), into L2/3 pyramidal neurons using IUE.
KCNQ2I205V offered the following three key advantages (Orhan et
al., 2014). First, no evidence suggests that it affects membrane traf-
ficking. Second, it acts as a dominant negative; therefore, the incor-
poration of one variant channel into a KCNQ2/3 heteromeric
complex is sufficient to alter the properties
of the channel. Third, the right-shifted con-
ductance-to-voltage relationship is not ex-
pected to reduce the mAHP, as the
KCNQ2I205V variant could still maximally
activate, albeit at more depolarized poten-
tials (V1/2;KCNQ2,25.21.9mV,n7;
KCNQ2I205V,10.6 3.1 mV, n 7; p	
0.01, Mann–Whitney test; Fig. 3A). There-
fore, any changes in KCNQ2I205V-express-
ing neuron excitability are expected to be
due to reduced KCNQ2/3 activity at sub-
thresholdmembrane potentials.
Consequently, we introduced
KCNQ2I205V into somatosensory L2/3
pyramidal neurons using IUE. This ap-
proach enabled us tomodify only a subset
of pyramidal neurons at an early develop-
mental stage, therefore nullifying the
complications of global excitability
changes (Chen et al., 2014b). Further-
more, we transfected mice from a wild-
type background to avoid potential
compensatory mechanisms resulting
from conditional Kcnq2 deletion; as a
dominant negative, the KCNQ2I205V vari-
ant is able to alter channel properties
without relying on molecular replace-
ment.We transfected the progenitors that
line the lateral ventricle at E15 with our
KCNQ2 constructs, because these cells
eventually become the pyramidal neurons
that migrate to L2/3 cortical layers. We
identified transfected neurons through
cotransfection of a monomeric red fluo-
rescent protein. Previous work has shown
that the efficiency of cotransfecting two
plasmids with IUE exceeds 90% (Chen et
al., 2014a; Siddiqi et al., 2014).
We recorded fromP15–P20 L2/3 pyra-
midal neurons using the same approach
that we used for Kcnq2 cKOmice. Similar
to the Kcnq2-null neurons, we found that the overexpression of
KCNQ2I205V increased L2/3 pyramidal neuron excitability (Fig.
3B,C). In particular, KCNQ2I205V-expressing neurons produced
a greater number of APs (150 pA step; KCNQ2, 7.1 1.5 APs,
n  10; KCNQ2I205V, 11.8  1.2 APs, n  8; p 	 0.05, Mann–
Whitney test) and faster initial and final frequencies for any given
stimulus (150 pA step, initial: KCNQ2, 14.3 3.4 Hz, n 10;
KCNQ2I205V, 42.8  11.8 Hz, n  8; p 	 0.01, Mann–Whitney
test;150 pA step, steady-state: KCNQ2, 5.1  1.2 Hz, n 10;
KCNQ2I205V 8.7 1.0 Hz, n 8; p	 0.05, Mann–Whitney test)
compared with neurons overexpressing wild-type KCNQ2 chan-
nels. Additionally, we found that the input resistance increased in
neurons expressing the KCNQ2I205V variant (KCNQ2, 245 27
M, n  10; KCNQ2I205V, 337  32 M, n  8; p 	 0.05,
Mann–Whitney test). Importantly, both the mAHP amplitude
and the charge between KCNQ2 and KCNQ2I205V neurons were
similar (Fig. 3D; mAHP: KCNQ2, 5.5  1.4 mV, n  7;
KCNQ2I205V,5.0 0.8 mV, n 4; p 0.77; charge: KCNQ2,
15.1 0.2 mV*s, n 7; KCNQ2I205V,14.7 0.4 mV*s, n
4; p  0.527, Mann–Whitney test), suggesting (1) that the ob-
served neuronal excitability effects were not due to loss of the
Figure 2. Kcnq2 ablation leads to increase neuronal excitability of L2/3 pyramidal neurons. A, Left, Representative voltage
responses to various current injection steps (1 s from50 to200 pA) in L2/3 pyramidal neurons from control or Kcnq2-null
neurons. Membrane potential was kept at84 mV by injecting a small direct current (DC) through the recording pipette. Right,
Summary graphs showing the effect of deleting KCNQ2 channels on AP number and the initial and final frequency (AP number:
F(4,148)9.37,p	0.0001; initial frequency: F(4,148)8.17,p	0.0001; final frequency: F(4,148)9.24;p	0.0001, two-factor
mixed-design ANOVA). B, Left, Representative voltage responses to a current injection ramp (2.5 s ramp from100 pA to200
pA; 0.1 nA/s) recorded from control or Kcnq2-null L2/3 pyramidal neurons. Right, summary graphs showing the effect of ablating
KCNQ2 channels on the number of APs during the ramp protocol (control: 9.2 1 APs, n 10; Kcnq2 cKO: 13.8 1 APs, n 12;
p	 0.05, Student’s t test). Using this protocol,we found that the rheobase for action potential generationwas lower inKcnq2-null
neurons (control: 196 9 pA, n 10; Kcnq2 cKO: 168 8 APs, n 12; p	 0.05, t 2.43, Student’s t test).We did not find any
significant differences in the resting membrane potential between control and Kcnq2-null neurons (control:67.3 0.8 mV,
n 49; Kcnq2 cKO:65.7 1.1 mV, n 39; p 0.2, Student’s t test). Asterisks indicate statistically significant differences
(*p	 0.05, ****p	 0.0001).
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Figure3. Loss-of-function KCNQ2 variant KCNQ2 I205V leads to L2/3 pyramidal neuron hyperexcitability. A, Left, Representative current responses to incremental voltage steps (1 s from
70 to40 mV) in HEK293t cells transfected with either wild-type KCNQ2 or KCNQ2 I205V. Right, Summary graph of conductance normalized to maximum conductance. Consistent with
previous studies, KCNQ2 I205V caused a right-shifted V1/2 in the conductance-to-voltage relationship (KCNQ2 WT:25.2 1.9 mV, n 7; KCNQ2
I205V:10.6 3.1 mV, n 7; p	
0.01, Mann–Whitney test) but did not affect the slope (KCNQ2 WT: 8.1 0.5, n 7; KCNQ2 I205V: 8.3 0.7, n 7; p 0.840, Mann–Whitney test). B, Left, Representative voltage
responses to various current injection steps (1 s from50 to200 pA) in L2/3 pyramidal neurons from cells expressing either KCNQ2 or KCNQ2 I205V. Membrane potential was kept at
84 mV by injecting a small DC current through the recording pipette. Right, Summary graphs showing the effect of expressing KCNQ2 I205V compared with cells expressing KCNQ2 in AP
number and initial and final frequency (AP number: F(4,64)  3.01, p 	 0.05; initial frequency: F(4,64)  5.00, p 	 0.01; final frequency: F(4,64)  3.95, p 	 0.01, two-factor
mixed-design ANOVA). C, Left, Representative voltage responses to a current injection ramp (2.5 s ramp from 100 to 200 pA; 0.1 nA/s) recorded from KCNQ2 or KCNQ2 I205V-
transfected neurons and L2/3 pyramidal neurons. Right, Summary graphs showing the effect of ablating KCNQ2 channels on the number of APs during the ramp protocol (KCNQ2: 7.6
1.6, n 10; KCNQ2 I205V: 14.0 2, n 8; p	 0.05, Mann–Whitney test). Using this protocol, we found that the rheobase for action potential generation was not significantly different
between KCNQ2 and KCNQ2 I205V-transfected neurons (KCNQ2: 202 14 pA, n 10; KCNQ2 I205V: 166 10 pA, n 8; p 0.1, Mann–Whitney test). D, Left, Representative voltage
responses to a strong but brief current step (2 nA, 50 ms) to induce spiking. Right, Summary graph showing a lack of difference in mAHP amplitude between neurons overexpressing
KCNQ2 wild-type or KCNQ I205V-variant channels (KCNQ2:5.5 1.4 mV, n 7; KCNQ2 I205V:5.0 0.8 mV, n 4; p 0.77, Mann–Whitney test). Asterisks indicate statistically
significant differences (*p	 0.05, **p	 0.01).
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mAHP and (2) that KCNQ2I205Vwas expressed in the transfected
neurons. Had the KCNQ2I205V variant failed to traffic or caused
a global KCNQ2 trafficking defect in L2/3 pyramidal neurons, we
should have also seen a loss to themAHP as we did with theKcnq2
cKO mice. We also note that, in contrast to transfected neurons,
neighboring untransfected pyramidal neurons from the two exper-
imental groups did not show any changes in their firing properties,
suggesting that the differences between KCNQ2 and KCNQ2I205V
transfected slices were likely cell autonomous (150 pA step; for
KCNQ2 transfected slices: 8.5  1.2 APs, n  4; for KCNQ2I205V
transfected slices: 9.31.1APs,n8;p0.8,Mann–Whitney test)
KCNQ2 ablation leads to action potential changes
KCNQ channels in cortical neurons are enriched in the AIS, where
they regulate sodium channel inactivation in part by setting the ax-
onal resting membrane potential (Battefeld et al., 2014). Recent
work has shown that hyperexcitability can
be accompanied by AIS changes, manifest-
ing as alterations in length, location, or ion
channel composition (Grubb and Burrone,
2010; Kaphzan et al., 2011; Hamada and
Kole, 2015). As the loss of KCNQ2 channels
leads to chronic hyperexcitability, we inves-
tigated whether action potential properties
and AIS length changed in Kcnq2-null
neurons.
First, we measured AP properties fol-
lowing a brief but large stimulation proto-
col (2 nA, 2 ms; Fig. 4A). Ablation of
Kcnq2 led to a larger AP amplitude (con-
trol: 121  2 mV, n  22; Kcnq2 cKO:
131 4 mV, n 16; p	 0.05, Student’s t
test). To better quantify differences in AP
properties between control and Kcnq2-
null neurons, we next took the first deriv-
ative (dV/dt) of the somatic recorded AP.
As with previous studies from multiple
groups, we found that the dV/dt exhibited
the following two inflections: the first in-
flection reflects the invasion of the AIS AP
at the soma; whereas the second inflection
represents the recruitment of the somato-
dendritic AP. By comparing the dV/dt val-
ues between wild-type and Kcnq2-null
neurons, we found that the first inflection
was larger (control: 38.5  3.2 mV/ms,
n  22; Kcnq2 cKO: 64.7  7.8 mV/ms,
n 16; p	 0.01, Student’s t test), whereas
the amplitude of the second inflectionwas
significantly smaller in the Kcnq2-null
neurons (control: 226  6 mV/ms, n 
22; Kcnq2 cKO: 182  8 mV/ms, n  16;
p	 0.0001, Student’s t test; Fig. 4A). The
smaller second inflection amplitude sug-
gests that sodium channels driving the so-
matodendritic AP inactivated more
readily in the Kcnq2-null neurons. This is
best illustrated in theAPphase plot, which
was dominated by the somatodendritic
component of the AP (Fig. 4A). In partic-
ular, Figure 4A shows that the peak AP
upstroke rate was significantly smaller
(control: 226  6, n  22; Kcnq2 cKO:
180  8, n  16; p 	 0.0001, Student’s t test), whereas the AP
thresholdmoved to higher values (control:51.4 1.6mV, n
22; Kcnq2 cKO: 36.7  5.0 mV, n  16; p 	 0.01, Student’s t
test). Both of these changes are consistent with increased sodium
channel inactivation in Kcnq2-null neurons (Battefeld et al.,
2014).
What could cause the increased AP amplitude and larger first
inflection in the AP dV/dt? One possibility includes changes in
AIS morphology or localization. To investigate this, we tested
whether the ablation ofKcnq2 also leads to changes in theAIS.We
performed immunohistochemistry in brain slices from control
and Kcnq2 cKO mice (Fig. 4B). We labeled the AIS using AnkG
due to its prevalence throughout the neuronal subcompartment
and its critical role in scaffolding sodium channels in the AIS
(Cooper, 2011). By comparing control and Kcnq2-null neurons,
we found that the AnkG length did not significantly change (Fig.
Figure4. Kcnq2ablation leads to changes inactionpotential properties.A, Left andmiddle, RepresentativeAPanddV/dt values
from control and Kcnq2-null L2/3 pyramidal neurons. Right, AP phase plot from control (n 22) and Kcnq2-null (n 16) L2/3
pyramidal neurons. AP threshold, defined as the voltage at 100 mV/ms, is more depolarized in Kcnq2-null neurons (control:
52.4 1.6mV, n 22; Kcnq2 cKO:36.7 5.0mV, n 16; p	 0.01, t 3.23, Student’s t test), and themaximum dV/dt
is reduced (control: 2266,n22;Kcnq2 cKO: 1808,n16;p	0.0001, t4.62, Student’s t test) comparedwith controls.
B, Representative confocal images of somatosensory cortex L2/3 neurons labeled for AnkG, PanNav, and DAPI to stain cell nuclei in
control mice (top) and Kcnq2 conditional knock-out mice (bottom). Scale bar, 20m. C, Summary graphs showing the effect of
Kcnq2 ablation onAnkG and PanNav length. Neither the length of AnkG (control: 37.2 1.5m; n 24; AIS, four animals; Kcnq2
cKO: 34.8 1.2 m; n 38; AIS, three animals; p 0.218, t 1.25, Student’s t test) nor the length of PanNav changed
significantly (control: 28.4 1.2m; n 24; AIS, four animals; Kcnq2 cKO: 30.2 1.0m; n 38; AIS, three animals; p
0.272, t 1.11, Student’s t test).
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4C). To measure the sodium channel distribution, we costained
the AIS with a PanNav antibody but also found that there was no
significant change in the PanNav length. Thus, the changes in the
action potential propertiesmay not be associated with alterations
in AIS length.
Inhibition of sodium channel Nav1.6 restores L2/3 excitability
inKcnq2-null neurons
Because KCNQ2 ablation leads to action potential changes, we
investigatedwhether targeting the sodium channel Nav1.6, which
localizes at theAIS and is responsible for AP generation (Hu et al.,
2009), is sufficient to dial down the hyperexcitability of Kcnq2-
null pyramidal neurons.
To directly test this, we took advantage of the TTX analog
4,9-ahTTX. Previous work has shown that 100 nM ahTTX blocks
50% of Nav1.6 when expressed in heterologous cells, with little to
no effect on Nav1.2—another key sodium channel expressed at
the AIS (Rosker et al., 2007; Hargus et al., 2013). Indeed, we
found that the application of 100 nM ahTTX to control neurons
significantly reduced the number of APs by almost 50% across a
range of stimuli (control: 8.8 1.1 to 5.0 0.7, n 5; p	 0.01,
paired Student’s t test; Fig. 5). In Kcnq2-null neurons, 100 nM
ahTTX decreased the AP number less robustly, but, importantly,
to levels similar to those of control neurons (Kcnq2 cKO: 11.7
0.6 to 8.6 1.3, n 8; p	 0.05, paired Student’s t test, Fig. 5B).
A similar decrease to control levels was found for the initial and
final frequencies (Fig. 5B).
Nav1.6 also contributes to the AP rheobase and resistance
(input resistance-ramp; RN-ramp) as neurons approach the AP
threshold. This is most evident when using a slow ramp protocol,
leading to the activation of a persistent sodium current, typically
active between70 and20 mV, which further drives the firing
of pyramidal neurons (Royeck et al., 2008). Indeed,we found that
in control neurons 100 nM ahTTX increased the rheobase
(194.3 5.2 to 236.5 19 pA, n 6; p	 0.05, paired Student’s
t test; Fig. 6) and decreased the approach slope to AP threshold,
measured as RN-ramp (236.0 15 to 200.3 13M; n 6; p	
0.001, paired Student’s t test; Fig. 6B), as expected for inhibiting
an inward sodium current. Surprisingly, ahTTX had minimal
effects on both the rheobase and RIN-ramp when using the slow
ramp protocol in Kcnq2-null neurons, despite reducing the AP
number (14.0  0.7 to 11.0  0.6; n  8; p 	 0.01, paired Stu-
dent’s t test, Fig. 6B). This suggests that the loss of KCNQ2 chan-
nels was also accompanied by a change in the contribution of
Nav1.6 channels to AP generation.
An inherent assumption to our interpretation is that ahTTX is
indeed a selective blocker of Nav1.6 channels in pyramidal neu-
rons.We tested this directly by comparing the effects of ahTTX in
control and Nav1.6-deficient neurons (Royeck et al., 2008). For
this experiment, we depolarized control and Nav1.6-deficient
neurons to elicit seven APs followed by bath application of 100
nM ahTTX. In control neurons, the application of ahTTX for
8–10minwas sufficient to block L2/3 pyramidal neuron firing. In
contrast, ahTTX application to Nav1.6-deficient neurons had lit-
tle effect (Fig. 7). This provides strong evidence that ahTTX is
indeed a selective blocker at the 100 nM concentration in neocor-
tical pyramidal neurons. We repeated this experiment in Kcnq2-
null neurons and found that the application of 100 nM ahTTX
Figure 5. The Nav1.6-specific blocker 4,9-anhydroTTX dampens the hyperexcitability of Kcnq2-null neurons. A, Representative voltage responses to100 pA current injection steps in control
(black traces) or Kcnq2-null (red traces) L2/3 pyramidal neurons in the presence or absence of 100 nM ahTTX. Membrane potential was kept at84mV by injecting a small DC current through the
recording pipette.B, Left, Summary graphs showing the effect of applying 100 nM ahTTX on the AP number and firing frequency of control (black) and Kcnq2-null (red) neurons (AP number: 8.8
1.1 to 5.0 0.7, n 5; p	 0.01, t 6.52; initial frequency: 15.9 2.8 to 7.2 1.6 Hz, n 5; p	 0.01, t 4.84; final frequency: 7.3 0.9 to 3.7 0.6 Hz, n 5; p	 0.01, t 5.63, paired
Student’s t test). Right, Summarygraphs showing that theapplicationof ahTTX reduces firingproperties ofKcnq2-null neurons (APnumber: 11.70.6 to8.61.3,n9;p	0.05, t3.63; initial
frequency: 22.5 1.4 to 14.4 2.0 Hz, n 9; p	 0.05, t 2.73; final frequency: 10.2 0.7 to 6.9 1.2 Hz, n 9; p	 0.05, t 2.91, paired Student’s t test). C, Summary graphs showing
that the application of ahTTX reduces Kcnq2-null neurons to control levels (AP number: control (ahTTX), 8.8 1.1, n 5; Kcnq2 cKO (ahTTX), 8.6 1.3, n 9; p 0.90; initial frequency:
control (ahTTX), 15.9 2.8 Hz, n 5; Kcnq2 cKO (ahTTX), 14.4 2.0 Hz, n 9; p 0.51; final frequency: control (ahTTX), 7.3 0.9 Hz, n 5; Kcnq2 cKO (ahTTX), 6.9 1.2 Hz, n
9; p 0.44; Mann–Whitney test). Asterisks indicate statistically significant differences (*p	 0.05, **p	 0.01).
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reduced the AP number by approximately the same amount as in
control cells (control: 6.8 0.1 to 4.4 0.5, n 11; p	 0.001;
Kcnq2 cKO: 7.2  0.1 to 4.0  1.0, n  6; p 	 0.05, paired
Student’s t test; Fig. 7), which is consistent with Nav1.6maintain-
ing persistent firing in Kcnq2-null neurons. To determine
whether the firing frequency changed, we measured the inter-
spike interval for cells before and after the addition of ahTTX.
Indeed, interspike intervals at both the onset and end of themea-
sured train showed decreased firing frequency (first interval: con-
trol, 10.9 1.0Hz to 7.6 1.0Hz, n 10; p	 0.001;Kcnq2 cKO,
10.6  0.7 Hz to 6.0  1.2 Hz, n  5; p 	 0.05; fourth interval:
control, 6.8 0.2Hz to 5.2 0.3Hz, n 10; p	 0.001, t 7.38;
Kcnq2 cKO, 6.7 0.2 Hz to 4.9 0.5 Hz, n 5; p	 0.05, paired
Student’s t test; Fig. 7). These data suggest that Nav1.6 is still
expressed in Kcnq2-null neurons and is critical for persistent fir-
ing, although not for setting the rheobase.
Discussion
KCNQ2 controls excitability in L2/3 somatosensory
pyramidal neurons
In this study, we used cortical Kcnq2 cKO mice to show for the
first time that the excitability of L2/3 pyramidal neurons critically
depends onKCNQ2 channel activity. In particular, we found that
Kcnq2 ablation led to an increased number of APs and to faster
initial and final firing frequencies, independent of the stimulus
protocol (step vs ramp). The elevated excitability was partly due
to changes in the input resistance ofKcnq2-null neurons. KCNQ2
channels typically begin activating close to the restingmembrane
potential, and their probability of opening increases as neurons
approach the AP threshold. As such, loss of this slow potassium
channel conductance would lead to an elevated input resistance.
Ourwork also extends earlier findings; for instance, a previous
study showed that the KCNQ channel blocker XE991 increased
the excitability of L2/3 pyramidal neurons, accompanied by an
increase in input resistance (Guan et al., 2011). However, this
study used low concentrations of XE991 (2M) that blocked only
a small portion of total KCNQ channel conductance, as higher,
more commonly used XE991 concentrations blocked the A-type
potassium current in L2/3 pyramidal neurons (Guan et al., 2011).
Other studies showed that the ablation ofKcnq2 using transgenic
mice or a reduction of KCNQ2/3 activity using mice carrying
BFNS variants also increased the excitability of CA1 pyramidal
neurons (Otto et al., 2006; Singh et al., 2008; Soh et al., 2014;
Kalappa et al., 2015). However, CA1 pyramidal neurons exhibit
strong spike frequency adaptation, and the ablation of KCNQ2
channels prevented this adaptation, allowing neurons to fire con-
tinuously in a regular pattern (Peters et al., 2005; Soh et al., 2014);
Figure 6. Kcnq2 ablation leads to a reduced role for Nav1.6 in regulating the intrinsic excitability of L2/3 pyramidal neuron. A, Representative voltage responses to a current injection ramp (2.5
s ramp from100 to200 pA; 0.1 nA/s) recorded from control (black traces) or Kcnq2-null (red traces) L2/3 pyramidal neurons in the presence or absence of 100 nM 4,9-ahTTX, a Nav1.6 blocker.
B, Left, Summary graphs showing the effect of 100nMahTTXon thenumber of APs, input resistance, and rheobase in control neurons (APnumber: 9.01.1 to 4.71.2,n6;p	0.01, t6.38;
rheobase: 1945 to23719pA,n6;p	0.05, t2.81; RN-ramp resistance: 23615 to20013M,n6;p	0.001, t6.97, pairedStudent’s t test). Right, Summarygraphs showing
the effect of 100 nM ahTTX on Kcnq2-null neurons when applying a slow ramp current injection (AP number: 14.0 0.7 to 11.0 0.6, n 8; p	 0.01, t 3.55; rheobase: 167 8 to 172 7
pA,n8;p0.468, t0.768; RN-ramp:32422 to29812M,n8;p0.0803, t2.04, pairedStudent’s t test). Asterisks indicate statistically significantdifferences (*p	0.05, **p	
0.01, ***p	 0.001).
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in contrast, L2/3 pyramidal neurons in
our study showed much less adaptation,
and the loss of KCNQ2 activity did not
alter L2/3 spike frequency adaptation, as
demonstrated by almost equal increases in
both the initial and final firing frequen-
cies. This suggests that channels other
than KCNQ2 primarily mediate L2/3
adaptation.
The KCNQ2I205V variant increases
neuronal activity similar to
KCNQ2 deletion
Within the last 4 years, 
50 mutations
relating to KCNQ2 encephalopathy have
been identified (Millichap et al., 2016).
Several of these variants right shift the
voltage activation of KCNQ2 channels to
more depolarized membrane potentials.
However, such variants would leave the
mAHP intact, making it difficult to pre-
dict their effect on neuronal excitability
and firing. We found that the overexpres-
sion of the KCNQ2I205V pathogenic vari-
ant (Weckhuysen et al., 2012) inwild-type
mice, and in a subset of L2/3 pyramidal
neurons, exhibited very similar neuro-
physiological phenotypes to Kcnq2-null
neurons. In particular, KCNQ2I205V-
expressing neurons produced more APs
with faster initial and final firing frequen-
cies than neurons overexpressing KCNQ2
wild-type channels (Fig. 3B).
One explanation for how the KCNQ2I205V variant increases
excitability stems from its altered channel properties. The
KCNQ2I205V variant shifts the voltage–activation curve of
KCNQ2/3 channels tomore depolarizedmembrane potentials, pre-
venting any significant activation of KCNQ2/3 channels at sub-
threshold membrane potentials—similar to neurons lacking
KCNQ2 channels. As the KCNQ2I205V variant is introduced in pro-
genitor cells, it is likely that the vast majority of KCNQ2/3 channels
are KCNQ2I205V/KCNQ3 by P15–P20. KCNQ2I205V is a dominant
negative, so the incorporation of even one copy of KCNQ2I205V
would be sufficient to change the biophysical properties of a
KCNQ2/3channel.Alternatively, the expressionof theKCNQ2I205V
variant could lead to a trafficking defect followed by decreased sur-
face expression of KCNQ2/3 channels. However, this seems un-
likely, as the mAHP measured in neurons expressing the wild-type
KCNQ2 or the KCNQ2I205V variant was similar (Fig. 3D). In our
protocol, themAHP reflects the opening of KCNQ2/3 channels fol-
lowing a 50 ms suprathreshold stimulus, depolarizing neurons well
beyond the activation range of both KCNQ2 and KCNQ2I205V
channels.Overall, ourdata suggest that the loss ofKCNQ2activity at
subthresholdmembranepotentials leads to largeexcitability changes
that are independent of changes to the mAHP.
KCNQ2 ablation alters action potential properties
Chronic changes in neuronal excitability could lead to both elec-
trophysiological and morphological changes in neurons. Recent
work has shown that neuronal activity can also have a profound
effect on the AIS—a neuronal subcompartment that is critical for
the generation of APs (Grubb and Burrone, 2010; Kaphzan et al.,
2011; Kole and Stuart, 2012; Hamada and Kole, 2015). In partic-
ular, elevated neuronal activity could shift the AIS toward the
soma and/or shorten its length. This compensatory response will
decrease neuronal excitability by shifting the AP initiation site
closer to the soma, thereby requiring a greater depolarization to
overcome the somatic capacitive load. However, costaining for
both the AIS marker AnkG and Nav channels did not reveal any
changes in AIS length in Kcnq2-null neurons, suggesting that
their hyperexcitability is not necessarily accompanied by altera-
tions in AIS localization.
But why does the action potential amplitude increase in
Kcnq2-null pyramidal neurons?We speculate that this might be a
side effect of neuronal compensation for the loss of KCNQ2
channels in the AIS. Previous studies using pharmacological ap-
proaches and modeling have shown that a lack of KCNQ2 chan-
nels would depolarize the AIS membrane potential (Battefeld et
al., 2014), leading to greater sodium channel inactivation and a
subsequently smaller AP amplitude. Onemechanism to counter-
act this effect would be to increase action potential amplitude,
which is driven by changes in sodium channel density and/or
voltage-gated sodium channel composition in the AIS. Such
changes might explain our seemingly contradictory finding of a
larger AP amplitude, yet decreased maximum upstroke rate. Fu-
ture studies are needed to determine whether Kcnq2 ablation
alters the sodium channel composition in the AIS.
Nav1.6 is a viable target to dampen KCNQ2-related
hyperexcitability
Current treatments for children with KCNQ2 encephalopathy
are limited. However, two possible interventions have been pro-
posed: (1) retigabine (or ezogabine); and (2) carbamazepine. Re-
Figure7. 4,9-AnhydroTTX is a selectiveNav1.6 blocker.A, Representative voltage responses to100pA current injection steps
(1) in control (black trace) or Scn8amed/ (blue traces) and Kcnq2-null (red traces) L2/3 pyramidal neurons in the presence or
absence of 100 nM 4,9-ahTTX. Membrane potential was kept at84 mV by injecting a small DC current through the recording
pipette. B, Summary graphs showing the effect of applying 100 nM 4,9-ahTTX on the AP number and firing frequency of control
(black) and Kcnq2-null (red) neurons (AP number: control, 6.8 0.1 to 4.4 0.5, n 11; p	 0.001, t 5.40; Kcnq2 cKO, 7.2
0.1 to 4.0 1.0,n 6; p	 0.05, t 3.15; first interval: control, 10.9 1.0 to 7.6 1.0Hz,n 10; p	 0.001, t 5.71; Kcnq2
cKO, 10.60.7 to 6.01.2Hz,n5;p	0.05, t3.34; fourth interval: control, 6.80.2 to 5.20.3Hz,n10;p	0.001,
t 7.38; Kcnq2 cKO, 6.7 0.2 to 4.9 0.5 Hz, n 5; p	 0.05, t 4.93, Student’s t test). Asterisks indicate statistically
significant differences (*p	 0.05, ***p	 0.001).
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tigabine is a specific Food and Drug Administration (FDA)-
approvedKCNQactivator (Blackburn-Munro et al., 2005; Boscia
et al., 2006; Gunthorpe et al., 2012) that works by stabilizing the
active conformation of KCNQ channels and improving their
ability to dampen neuronal excitability (Wuttke et al., 2005). As
one copy of wild-type KCNQ2 channels is still present in children
with KCNQ2 encephalopathy, the application of retigabine can
still open KCNQ2/3 channels. However, it is currently unknown
whether all KCNQ variants will respond similarly to retigabine.
Additionally, several adverse effects have further limited the use
of retigabine in patients (Jankovic and Ilickovic, 2013). Recently,
carbamazepine, an FDA-approved compound that reduces so-
dium channel activity, was proposed as a first-in-line compound
to treat patients with KCNQ2 encephalopathy (Pisano et al.,
2015; Auvin et al., 2016). However, it is unclear which specific
sodium channels are responsible for the effects produced by car-
bamazepine, and not all patients with KCNQ2 encephalopathy
respond to carbamazepine (Weckhuysen et al., 2012; Pisano et
al., 2015).
Here, we propose Nav1.6 as a new molecular target to da-
mpen KCNQ2-mediated neuronal excitability. Nav1.6 colocalizes
with KCNQ2/3 channels (Battefeld et al., 2014); thus, the loss of
KCNQ2/3 channels may lead to unchecked Nav1.6 activity. This is
particularly important as Nav1.6 also partially mediates the afterde-
polarization followingAPs in somepyramidalneurons, aswell as the
persistent sodium current in cortical neurons (Golomb et al., 2006;
Royeck et al., 2008). Importantly, KCNQ2/3 channels are known to
limit the activity of these conductances (Yue and Yaari, 2004;
Golomb et al., 2006).We found that the reduction ofNav1.6 activity
using the TTX metabolite ahTTX led to a decrease in the number
and frequencyofAPs, independentof the stimulationprotocol (Figs.
5, 6). Interestingly, reducing Nav1.6 activity with 100 nM ahTTX in
Kcnq2-nullneuronsdecreasedexcitability tonear-control levels.The
addition of ahTTX on control neurons also increased the rheobase
and decreased resistance (RN-ramp) whenmeasured with the ramp
protocol, which is consistent with previous work using Nav1.6
knock-out mice to show that Nav1.6 partly mediates the persistent
sodium current (Royeck et al., 2008). However, we did not see any
changes in rheobase or RN-rampwhenwe applied ahTTX inKcnq2-
null neurons (Fig. 6B).We foresee twopossible explanations for this
finding. First, a different set of sodium channels are now critical for
setting the rheobase of APs in L2/3 neurons. One major candidate
would be Nav1.2, which is also found in the AIS of pyramidal neu-
rons and contributes to AP generation. Second, ablating KCNQ2
channels leads to a large Nav1.6-mediated conductance, such that
ahTTX at 100 nM is insufficient to counteract its activity. This seems
less likely, as the application of ahTTX was sufficient to reduce the
persistentL2/3 firing inbothwild-typeandKcnq2-nullneurons (Fig.
7). Overall, the ability to reduce continuous AP firing to near-
normal levels in Kcnq2-null neurons suggests that Nav1.6 may in-
deed be a successful target for reducing KCNQ2-related neuronal
hyperexcitability.
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